ABN AMRO Investment Solutions’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $388K | Buy |
4,450
+441
| +11% | +$38.5K | 0.01% | 365 |
|
2025
Q1 | $274K | Sell |
4,009
-4,053
| -50% | -$277K | 0.01% | 391 |
|
2024
Q4 | $627K | Buy |
8,062
+2,346
| +41% | +$182K | 0.01% | 332 |
|
2024
Q3 | $383K | Sell |
5,716
-29,018
| -84% | -$1.95M | 0.01% | 419 |
|
2024
Q2 | $3.94M | Buy |
34,734
+12,319
| +55% | +$1.4M | 0.07% | 175 |
|
2024
Q1 | $3.11M | Buy |
22,415
+642
| +3% | +$89K | 0.05% | 216 |
|
2023
Q4 | $2.7M | Buy |
21,773
+20
| +0.1% | +$2.48K | 0.05% | 231 |
|
2023
Q3 | $2.03M | Buy |
21,753
+13,032
| +149% | +$1.22M | 0.04% | 249 |
|
2023
Q2 | $1.12M | Sell |
8,721
-300
| -3% | -$38.6K | 0.02% | 282 |
|
2023
Q1 | $1.05M | Buy |
+9,021
| New | +$1.05M | 0.02% | 303 |
|